MERCK

Drug Name	Phase	Indication	Designations
Opevesostat	Phase 3	Prostate Cancer Metastatic	-
Capecitabine	Phase 3	Advanced/Metastatic Gastroesophageal Adenocarcinoma	-
100 mg clindamycin /800 mg ketoconazole vaginal ovule	Phase 3	Vaginosis, Bacterial	-
QIV	Phase 3	Pneumonia, Pneumococcal	-
Ipilimumab	Phase 3	Melanoma	-
taranabant	Phase 3	Smoking	-
Nab-paclitaxel	Phase 3	Non-small Cell Lung Cancer	-
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks	Phase 3	Measles	-
V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years	Phase 3	Cervical Cancer	-
Enfortumab Vedotin	Phase 3	Urinary Bladder Cancer, Muscle-invasive	-
Cladribine Low Dose	Phase 3	Generalized Myasthenia Gravis	-
Metformin	Phase 3	Diabetes Mellitus	-
Colistimethate sodium (CMS)	Phase 3	Bacterial Infections	-
Acarbose	Phase 3	Type 2 Diabetes Mellitus	-
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine	Phase 3	HPV Infections	-
2XP HEPTAVAX™-II SC	Phase 3	Hepatitis B	-
DOR	Phase 3	HIV-1 Infection	-
denufosol tetrasodium (INS37217) Inhalation Solution	Phase 3	Cystic Fibrosis	-
succinylcholine	Phase 3	Neuromuscular Blockade	-
MK-1084	Phase 3	Colon Adenocarcinoma	-
V503 Vaccine	Phase 3	Papillomavirus Infections	-
Saizen® A	Phase 3	Children Born With Serious Intra-uterine Growth Retardation	-
Modified Process Hepatitis B Vaccine	Phase 3	Hepatitis B	-
MK0557	Phase 3	Obesity	-
Pembrolizumab Formulated with Berahyaluronidase Alfa	Phase 3	Metastatic Non-small Cell Lung Cancer	-
Pneumovax™ 23	Phase 3	Pneumococcal Infections	-
Posaconazole	Phase 3	Mycoses	-
Metformin - Rescue	Phase 3	Diabetes Mellitus, Type 2	-
Infanrix® hexa	Phase 3	Varicella	-
IV Tulisokibart	Phase 3	Crohn's Disease	-
Daptomycin 4 mg/kg	Phase 3	Staphylococcal Infection	-
Gonalef® (Follitropin alfa)	Phase 3	Infertility	-
Fluconazole	Phase 3	Leukopenia	-
MK0826, ertapenem sodium / Duration of Treatment - 24 weeks	Phase 3	Foot Infections in Diabetic Patients	-
Naproxen	Phase 3	Endometriosis-related Pain	-
fidaxomicin	Phase 3	Clostridium Difficile-Associated Diarrhea (CDAD)	-
Zoster Vaccine, Live	Phase 3	Herpes Zoster	-
losartan potassium	Phase 3	Hypertension	-
anacetrapib	Phase 3	Coronary Heart Disease (CHD)	-
dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-
rofecoxib	Phase 3	Prostate Cancer	-
ProQuad®	Phase 3	Measles	-
RotaTeq™, rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-
Quadrivalent Human Papillomavirus (HPV, Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)	Phase 3	Papillomavirus Infections	-
Infliximab + methotrexate (IFX + MTX)	Phase 3	Arthritis, Psoriatic	-
Rebif New Formulation + prophylactic Ibuprofen	Phase 3	Relapsing Multiple Sclerosis	-
PPSV23	Phase 3	Pneumococcal Disease	-
Boceprevir	Phase 3	Chronic Hepatitis C Genotype 1	-
Esmirtazapine	Phase 3	Insomnia	-
hydrochlorothiazide (HCTZ)	Phase 3	Hypertension	-
PNEUMOVAX™23	Phase 3	Pneumococcal Infections	-
Ertapenem sodium	Phase 3	Infection; Diabetic Foot	-
Prednisone	Phase 3	Prostatic Neoplasms	-
niacin (+) laropiprant (+) simvastatin	Phase 3	Primary Hypercholesterolemia	-
Modified Process Hepatitis B Vaccine (Experimental)	Phase 3	Hepatitis B	-
V212	Phase 3	Herpes Zoster	-
Dexamethasone 4 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-
Combination of pegylated interferon alfa-2b (PEG-Intron®) and ribavirin (Rebetol®)	Phase 3	Hepatitis C, Chronic	-
Open-label Metformin	Phase 3	Type 2 Diabetes	-
Olaparib	Phase 3	Ovarian Cancer	-
Pembrolizumab 400 mg	Phase 3	Small Cell Lung Cancer	-
RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent	Phase 3	Vomiting	-
docetaxel	Phase 3	Endometrial Neoplasms	-
Rescue Medications	Phase 3	Cervical Cancer	-
MTX	Phase 3	Arthritis, Rheumatoid	-
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine	Phase 3	Cervical Cancer	-
V920 Consistency Lot A	Phase 3	Prevention of Ebola Infection	-
Peginterferon alfa-2a	Phase 3	Hepatitis C, Chronic	-
Letermovir	Phase 3	Cytomegalovirus Infection	-
Sacituzumab tirumotecan	Phase 3	Colorectal Cancer	-
V232 Modified Process Hepatitis B Vaccine: Lot A	Phase 3	Hepatitis B Infection	-
PCV13	Phase 3	Pneumococcal Infections	-
Varicella Virus Vaccine Live (2007 Process) (Oka/Merck)	Phase 3	Varicella	-
Ribavirin	Phase 3	Hepatitis C	-
Anacetrapib 100 mg	Phase 3	Hypercholesterolemia	-
Gardasil™	Phase 3	Papillomavirus Infections	-
HBVAXPRO™	Phase 3	Hepatitis B	-
VARIVAX™	Phase 3	Varicella	-
SC Tulisokibart	Phase 3	Ulcerative Colitis	-
Insulin	Phase 3	Type 2 Diabetes Mellitus	-
Vericiguat	Phase 3	Heart Failure	-
etoposide	Phase 3	Carcinoma, Non-Small-Cell Lung	-
IMI/REL FDC	Phase 3	Hospital-Acquired Bacterial Pneumonia	-
Vicriviroc	Phase 3	HIV Infections	-
Molnupiravir	Phase 3	Coronavirus Disease (COVID-19)	-
losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E)	Phase 3	Hypertension	-
ertapenem sodium (MK0826)	Phase 3	Urinary Tract Infection	-
Pegylated liposomal doxorubicin (SCH 200746)	Phase 3	Breast Cancer	-
Enzalutamide	Phase 3	Metastatic Hormone-Sensitive Prostate Cancer	-
peginterferon alfa-2b (SCH 54031)	Phase 3	Chronic Hepatitis C	-
Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin	Phase 3	Hepatitis C, Chronic	-
Pembrolizumab SC	Phase 3	Non-Small Cell Lung Cancer	-
ISL	Phase 3	Human Immunodeficiency Virus Type 1 (HIV-1) Infection	-
TR-701 FA	Phase 3	Skin and Subcutaneous Tissue Bacterial Infections	-
Neostigmine	Phase 3	Anesthesia	-
5-Fluorouracil	Phase 3	Uterine Cervical Neoplasms	-
CB-183,315	Phase 3	Clostridium Difficile Infection	-
Pioglitazone	Phase 3	Type 2 Diabetes Mellitus	-
ceftriaxone sodium	Phase 3	Infection	-
PCV15	Phase 3	Pneumonia, Pneumococcal	-
eribulin	Phase 3	Metastatic Triple Negative Breast Cancer	-
Sitagliptin 50 mg	Phase 3	Type 2 Diabetes Mellitus	-
Preservative-Free Tafluprost or vehicle	Phase 3	Glaucoma	-
Preladenant 2 mg tablet	Phase 3	Parkinson Disease	-
Recombinant human luteinizing hormone (r-hLH)	Phase 3	Hypogonadism	-
Experimental: V503	Phase 3	Cervical Cancer	-
Peginterferon alfa-2b (PegIntron, SCH 54031)	Phase 3	Hepatitis D, Chronic	-
RNF	Phase 3	Multiple Sclerosis	-
H1 receptor antagonist	Phase 3	Ovarian Cancer	-
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years	Phase 3	Cervical Cancer	-
Telcagepant potassium 150 mg	Phase 3	Migraine	-
Hepatitis A Vaccine, Purified Inactivated (VAQTA™)	Phase 3	Hepatitis A Virus Infection	-
Vancomycin	Phase 3	Clostridium Difficile Infection	-
Ondansetron	Phase 3	Chemotherapy-Induced Nausea and Vomiting (CINV)	-
Anagrelide	Phase 3	Essential Thrombocythemia	-
ULO	Phase 3	Human Immunodeficiency Virus Type 1 (HIV-1) Infection	-
Telcagepant 140 mg	Phase 3	Migraines	-
Telcagepant 300 mg soft gel capsules	Phase 3	Migraine	-
Leucovorin	Phase 3	Gastric Cancer	-
Rotarix™	Phase 3	Pneumococcal Infections	-
Efalizumab	Phase 3	Moderate to Severe Psoriasis	-
Suvorexant High Dose (HD)	Phase 3	Primary Insomnia	-
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)	Phase 3	Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer	-
Uridine 5'-Triphosphate (UTP) Solution for Inhalation	Phase 3	Lung Cancer	-
Glycopyrrolate	Phase 3	Surgical Procedures, Elective	-
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™)	Phase 3	Rotavirus	-
ART	Phase 3	HIV-1 Infection	-
Linezolid	Phase 3	Pneumonia	-
REBETOL (ribavirin; SCH 18908)	Phase 3	Hepatitis C, Chronic	-
AzaSite	Phase 3	Bacterial Conjunctivitis	-
rosiglitazone	Phase 3	Type 2 Diabetes Mellitus	-
VARIVAX™ New Seed Process	Phase 3	Varicella	-
Cetuximab plus Platinum-based Doublet Chemotherapy	Phase 3	Non-Small Cell Lung Cancer (NSCLC)	-
ribavirin (SCH 18908)	Phase 3	Hepatitis C, Chronic	-
MK-0524B	Phase 3	Primary Hypercholesterolemia	-
Cyclophosphamide	Phase 3	Diffuse Large B-Cell Lymphoma	-
lovastatin	Phase 3	Atherosclerosis	-
MMRV (AMP)	Phase 3	Measles	-
Folinic Acid	Phase 3	Metastatic Colorectal Cancer	-
Lamivudine	Phase 3	HIV Infections	-
RotaTeq™ experimental formulation	Phase 3	Rotavirus Gastroenteritis	-
Ifinatamab Deruxtecan	Phase 3	Castration-Resistant Prostatic Cancer	-
Insulin Glargine	Phase 3	Type 2 Diabetes Mellitus	-
Bomedemstat	Phase 3	Thrombocythemia, Essential	-
Sulfonylurea	Phase 3	Type 2 Diabetes Mellitus	-
Pembrolizumab (MK-3475)	Phase 3	Merkel Cell Carcinoma	-
Hydroxyurea	Phase 3	Essential Thrombocythemia	-
Zidovudine	Phase 3	HIV Infections	-
Glimepiride	Phase 3	Type 2 Diabetes Mellitus	-
MK-0518	Phase 3	HIV Infections	-
Grazoprevir 100mg / Elbasvir 50 mg FDC	Phase 3	Chronic Hepatitis C Virus	-
Kuvan®	Phase 3	Phenylketonuria	-
Pioglitazone hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-
MK-8527	Phase 3	Human Immunodeficiency Virus (HIV)	-
PCV15 - Part B	Phase 3	Pneumococcal Disease	-
Zilovertamab vedotin	Phase 3	B-cell Acute Lymphoblastic Leukemia	-
Doravirine, Tenofovir, Lamivudine	Phase 3	HIV-1 Infection	-
Pembrolizumab/Quavonlimab	Phase 3	Colorectal Cancer	-
MK-5172A	Phase 3	Chronic Hepatitis C	-
PegIntron (peginterferon alfa-2b; SCH 54031)	Phase 3	Hepatitis	-
Grazoprevir	Phase 3	Chronic Hepatitis C (CHC)	-
PEG-Intron	Phase 3	Hepatitis C	-
Granulocyte Colony-Stimulating Factor (G-CSF)	Phase 3	DLBCL	-
Fosaprepitant dimeglumine	Phase 3	Chemotherapy-Induced Nausea and Vomiting (CINV)	-
Aprepitant 125 mg	Phase 3	Chemotherapy Induced Nausea and Vomiting	-
Human Papillomavirus (HPV) 16 Monovalent	Phase 3	Cervical Cancer	-
Atropine	Phase 3	Anesthesia, General	-
Glycemic Rescue 1	Phase 3	Diabetes Mellitus	-
Sitagliptin 100 mg q.d.+ Pioglitazone 45 mg q.d.	Phase 3	Type 2 Diabetes Mellitus	-
Androgen Deprivation Therapy (ADT)	Phase 3	Metastatic Hormone-Sensitive Prostate Cancer	-
ZOSTAVAX	Phase 3	Herpes Zoster	-
Cisplatin (as radiosensitizer)	Phase 3	Endometrial Neoplasms	-
Boceprevir (BOC)	Phase 3	Chronic Hepatitis C	-
Intismeran autogene	Phase 3	Bladder Cancer	-
MK0869, aprepitant	Phase 3	Postoperative Nausea and Vomiting	-
Cabozantinib	Phase 3	Renal Cell Carcinoma (RCC)	-
Voriconazole	Phase 3	Aspergillosis	-
Short ragweed pollen allergen extract	Phase 3	Rhinitis, Allergic, Seasonal	-
MK0803, lovastatin	Phase 3	Hypercholesterolemia	-
Trifluridine-Tipiracil	Phase 3	Gastroesophageal Cancer	-
Rescue medication	Phase 3	Non-Muscle Invasive Bladder Cancer	-
niacin (+) laropiprant	Phase 3	Hypercholesterolemia	-
TAS-102 (trifluridine and tipiracil)	Phase 3	Colorectal Neoplasms	-
Diquafosol tetrasodium ophthalmic solution, 2%	Phase 3	Dry Eye Disease	-
Gefapixant 15 mg BID	Phase 3	Chronic Cough	-
Standard of Care (SOC)	Phase 3	Solid Tumors	-
Enalapril	Phase 3	Hypertension	-
Tedizolid phosphate	Phase 3	Acute Bacterial Skin and Skin Structure Infections	-
SC golimumab	Phase 3	Arthritis, Rheumatoid	-
MK-1293	Phase 3	Type 1 Diabetes Mellitus	-
CXA-201 and metronidazole	Phase 3	Complicated Intra-abdominal Infection	-
PAR-101/OPT-80	Phase 3	Clostridium Infections	-
ZOSTAVAX™	Phase 3	Herpes Zoster	-
cetuximab + cisplatin + vinorelbine	Phase 3	Non Small Cell Lung Cancer (NSCLC)	-
sitagliptin 100 mg q.d./metformin ≥ 1500 mg/day	Phase 3	Type 2 Diabetes Mellitus (T2DM)	-
Elbasvir	Phase 3	Hepatitis C	-
Zanzalintinib	Phase 3	Renal Cell Carcinoma	-
methotrexate	Phase 3	Psoriasis	-
5-FU	Phase 3	Metastatic Esophageal Squamous Cell Carcinoma	-
Vorinostat	Phase 3	Mesothelioma	-
Oxaliplatin	Phase 3	Colorectal Neoplasms	-
rolofylline	Phase 3	Heart Failure, Congestive	-
Gardasil	Phase 3	Papillomavirus Infections	-
Cetrorelix acetate	Phase 3	Polycystic Ovarian Syndrome	-
MK0966 / Duration of Treatment: 1 Days	Phase 3	Pain, Postoperative Arthroscopy	-
RotaTeq (V260)	Phase 3	Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9	-
Aprepitant	Phase 3	Post-operative Nausea	-
Pembrolizumab/Vibostolimab	Phase 3	Lung Neoplasms	-
caspofungin acetate	Phase 3	Fungal Infection	-
MK0826, ertapenem sodium	Phase 3	Infections	-
Pembrolizumab (+) Berahyaluronidase alfa	Phase 3	Lung Cancer	-
Paclitaxel	Phase 3	Metastatic Non-Small Cell Lung Cancer	-
MK-6072	Phase 3	Clostridium Difficile Infection	-
Gliclazide	Phase 3	Type 2 Diabetes Mellitus	-
MK-0524A	Phase 3	Hypercholesteremia	-
Supportive care measures	Phase 3	Non-small Cell Lung Cancer (NSCLC)	-
ZOSTAVAX™ (concomitant)	Phase 3	Herpes Zoster	-
Doxorubicin	Phase 3	Breast Neoplasms	-
MK0974 50 mg	Phase 3	Migraine	-
Vitamin D3	Phase 3	Osteoporosis	-
MK0869, aprepitant / Duration of Treatment: 3 days	Phase 3	Nausea	-
neostigmine and glycopyrrolate or atropine	Phase 3	Neuromuscular Blockade	-
INS365 Ophthalmic Solution	Phase 3	Keratoconjunctivitis Sicca	-
Glipizide	Phase 3	Diabetes Mellitus, Type 2	-
Dexamethasone	Phase 3	Metastatic Castration-resistant Prostate Cancer (mCRPC)	-
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®	Phase 3	Measles	-
regorafenib	Phase 3	Colorectal Cancer	-
sitagliptin phosphate (+) metformin hydrochloride	Phase 3	Type 2 Diabetes Mellitus	-
V110, pneumococcal vaccine polyvalent	Phase 3	Healthy	-
Reformulated Raltegravir	Phase 3	HIV Infection	-
Background PAH Therapy	Phase 3	Pulmonary Arterial Hypertension	-
BIC/FTC/TAF	Phase 3	HIV-1 Infection	-
MK0991, caspofungin acetate / Duration of Treatment:	Phase 3	Fungal Infection	-
daptomycin	Phase 3	Pneumonia, Bacterial	-
Ertugliflozin 5 mg	Phase 3	Type 2 Diabetes Mellitus	-
Carboplatin	Phase 3	Carcinoma, Squamous Cell, Non-small-cell Lung	-
alvimopan	Phase 3	Ileus	-
pembrolizumab	Phase 3	Non-small Cell Lung Cancer	-
Nemtabrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
Prevnar 13™	Phase 3	Pneumococcal Infections	-
Zoster Vaccine, Live (Zostavax™)	Phase 3	Shingles	-
DOR/ISL	Phase 3	HIV Infection	-
Rocuronium bromide (Org 9426)	Phase 3	Muscle Relaxation	-
Rocuronium 0.6 mg/kg intubating dose	Phase 3	Anesthesia	-
Rocuronium bolus maintenance	Phase 3	Anesthesia	-
V114	Phase 3	Pneumococcal Infections	-
sitagliptin phosphate	Phase 3	Type 2 Diabetes	-
Infliximab	Phase 3	Psoriasis	-
Ertugliflozin 15 mg	Phase 3	Type 2 Diabetes Mellitus	-
Metformin IR	Phase 3	Type 2 Diabetes Mellitus	-
Zoster Vaccine Live	Phase 3	Herpes Zoster	-
ER niacin/laropiprant	Phase 3	Diabetes Mellitus Type 2	-
Grazoprevir + Elbasvir	Phase 3	Hepatitis C Infection	-
Cetuximab + concomitant boost radiotherapy	Phase 3	Squamous Cell Carcinoma of the Head and Neck	-
L50/H12.5/A5	Phase 3	Hypertension	-
MK0826, /Duration of Treatment : 8 Weeks	Phase 3	Complicated Intra-Abdominal Infections	-
bortezomib	Phase 3	Multiple Myeloma	-
sugammadex	Phase 3	Neuromuscular Blockade	-
Tedizolid Phophate	Phase 3	Skin Diseases, Infectious	-
MK0507A, dorzolamide hydrochloride (+) timolol maleate	Phase 3	Glaucoma	-
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 24 weeks	Phase 3	Osteoporosis	-
raltegravir potassium	Phase 3	HIV Infections	-
rotavirus vaccine, live, oral, pentavalent	Phase 3	Rotavirus Infections	-
Grazoprevir/Elbasvir	Phase 3	Hepatitis C	-
Temozolomide	Phase 3	Glioblastoma	-
Cisplatin	Phase 3	Gastric Neoplasms	-
laropiprant/niacin (MK0524A)	Phase 3	Hypercholesterolemia	-
Sitagliptin	Phase 3	Type 2 Diabetes Mellitus	-
9vHPV vaccine	Phase 3	Papillomavirus Infections	-
Gonal-f®	Phase 3	Assisted Reproductive Techniques	-
Ibrutinib	Phase 3	Chronic Lymphocytic Leukemia	-
COL-1620	Phase 3	Luteal Hormone Supplementation in In-vitro Fertilization	-
V441, diptheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant), & Haemophilus influenza type b conjugate vaccine	Phase 3	Diphtheria	-
V501	Phase 3	Human	-
losartan potassium (+) hydrochlorothiazide	Phase 3	Hypertension	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-
Bezlotoxumab	Phase 3	Clostridium Difficile Infection	-
PCV20	Phase 3	Pneumococcal Infection	-
Ertugliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Peginterferon alfa-2b	Phase 3	Carcinoma, Hepatocellular	-
Ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-
Rocuronium bromide	Phase 3	Anesthesia	-
Pemetrexed	Phase 3	Carcinoma, Nonsquamous Non-small-cell Lung	-
IMI/REL	Phase 3	Suspected or Documented Gram-negative Bacterial Infection	-
MK0966, rofecoxib	Phase 3	Postoperative Pain	-
Posaconazole oral suspension	Phase 3	Mycoses	-
Follitropin alfa liquid formulation	Phase 3	Infertility	-
Micronised Progesterone	Phase 3	Infertility	-
Imipenem+Cilastatin/Relebactam	Phase 3	Complicated Intra-abdominal Infection	-
zoster vaccine live (ZOSTAVAX™)	Phase 3	Herpes Zoster	-
Doravirine	Phase 3	HIV-1	-
Telcagepant	Phase 3	Migraine	-
Lenvatinib	Phase 3	Non-small Cell Lung Cancer	-
V503 (9-valent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] vaccine)	Phase 3	Human Papillomavirus Infection	-
V116	Phase 3	Pneumococcal Infection	-
Omarigliptin	Phase 3	Type 2 Diabetes Mellitus	-
MR Prednisone	Phase 3	Rheumatoid Arthritis	-
Pembrolizumab 200 mg	Phase 3	Non-Small-Cell Lung Carcinoma	-
Enfortumab vedotin (EV)	Phase 3	Bladder Cancer	-
Cetuximab	Phase 3	Gastric Cancer	-
Combination of (a) pegylated interferon alfa-2b and (b) rebetol	Phase 3	Liver Transplantation	-
Gefapixant 45 mg twice daily (BID)	Phase 3	Chronic Cough	-
Gefapixant	Phase 3	Chronic Cough	-
Indinavir sulfate	Phase 3	HIV Infections	-
Ridaforolimus	Phase 3	Sarcoma	-
V503	Phase 3	Papillomavirus Infections	-
Pembrolizumab/Vibostolimab Co-Formulation	Phase 3	Small Cell Lung Carcinoma	-
Prevnar 13®	Phase 3	Streptococcus Pneumoniae Infection	-
Saizen®	Phase 3	Fibromyalgia	-
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live	Phase 3	Measles	-
mFOLFOX6	Phase 3	Colorectal Carcinoma	-
Sitagliptin (MK0431)	Phase 3	Diabetes Mellitus, Type II	-
Cisplatin 100 mg/m^2	Phase 3	Head and Neck Neoplasms	-
Efavirenz	Phase 3	HIV Infections	-
Enlicitide Decanoate	Phase 3	Hypercholesterolemia	-
Odanacatib	Phase 3	Osteoporosis Postmenopausal	-
pegylated interferon alpha-2b	Phase 3	Hepatitis B, Chronic	-
V419	Phase 3	Bacterial Infections	-
Suvorexant	Phase 3	Insomnia	-
Rocuronium	Phase 3	Anesthesia, General	-
Gemcitabine	Phase 3	Biliary Tract Carcinoma	-
vaniprevir	Phase 3	Hepatitis C, Chronic	-
VARIVAX® PE34 Process	Phase 3	Varicella	-
Belzutifan	Phase 3	Renal Cell Carcinoma	-
Vorapaxar 2.5 mg	Phase 3	Cerebral Infarction	-
Rocurium	Phase 3	Anesthesia, General	-
MK1903	Phase 2	Dyslipidemia	-
ADL5859	Phase 2	Peripheral Neuropathy	-
MK2461	Phase 2	Neoplasm	-
denufosol tetrasodium (INS37217)	Phase 2	Cystic Fibrosis	-
OPT-80	Phase 2	Diarrhea	-
r-hFSH	Phase 2	Infertility	-
NM283 plus Peg-IFNα-2a	Phase 2	Chronic Hepatitis C	-
Everolimus	Phase 2	Metastatic Breast Cancer	-
SCH 727965	Phase 2	Breast Neoplasms	-
Dalotuzumab	Phase 2	Carcinoma, Non-small-cell Lung	-
MK-8777	Phase 2	Depression	-
MK0991, caspofungin acetate	Phase 2	Aspergillosis	-
Patritumab Deruxtecan	Phase 2	Malignant Neoplasm	-
ARQ 197	Phase 2	Pancreatic Neoplasms	-
SCH 486757	Phase 2	Cough	-
Tecemotide (L-BLP25)	Phase 2	Lung Neoplasms	-
ARQ 501	Phase 2	Cancer	-
Robatumumab	Phase 2	Colorectal Cancer	-
ADL5945 0.1 mg	Phase 2	Opioid Induced Constipation	-
MK0431, sitagliptin phosphate / Duration of Treatment: 21 Weeks	Phase 2	Diabetes Mellitus, Type II	-
measles, mumps, and rubella virus vaccine live	Phase 2	Measles	-
M5717 330 mg	Phase 2	Acute Malaria	-
V114-A	Phase 2	Pneumococcal Infections	-
Pegylated Liposomal Doxorubicin	Phase 2	Breast Neoplasm	-
Vecuronium	Phase 2	Anesthesia, General	-
MK0822A	Phase 2	Vitamin D Deficiency	-
Frespaciguat	Phase 2	Pulmonary Hypertension	-
Vibostolimab	Phase 2	Melanoma	-
MK0493	Phase 2	Obesity	-
MK0812 / Duration of Treatment: 12 Weeks	Phase 2	Arthritis, Rheumatoid	-
MK0633	Phase 2	Atherosclerosis	-
Tepotinib 300 mg	Phase 2	Carcinoma, Hepatocellular	-
Cilengitide	Phase 2	Carcinoma, Non-Small-Cell Lung	-
INS37217 Nasal Spray	Phase 2	Perennial Allergic Rhinitis	-
Cilengitide 2000 mg once weekly	Phase 2	Squamous Cell Cancer	-
MK0777	Phase 2	Generalized Anxiety Disorder	-
Avastin	Phase 2	High-grade Serous Ovarian Carcinoma	-
MK0686	Phase 2	Pain, Postoperative	-
ecallantide	Phase 2	Bloodloss	-
Uprifosbuvir	Phase 2	Hepatitis C	-
Atacicept	Phase 2	Rheumatoid Arthritis	-
Sitagliptin 25 mg	Phase 2	Glucose Intolerance	-
Pneumococcal Conjugate Vaccine (V114)	Phase 2	Pneumococcal Infections	-
Vibegron	Phase 2	Urinary Bladder, Overactive	-
BCG	Phase 2	Urinary Bladder Neoplasms	-
V114 Aluminum-adjuvanted	Phase 2	Pneumococcal Infections	-
Pembrolizumab (neoadjuvant)	Phase 2	Lung Neoplasm Malignant	-
Vibostolimab/Pembrolizumab	Phase 2	Carcinoma, Renal Cell	-
ADL5945 0.25 mg	Phase 2	Constipation	-
MK-3120	Phase 2	Urothelial Carcinoma	-
MK0431, sitagliptin phosphate / Duration of Treatment: 12 Weeks	Phase 2	Type 2 Diabetes Mellitus	-
Org 34517	Phase 2	Depression	-
Navarixin	Phase 2	Solid Tumors	-
Daptomycin for Injection	Phase 2	Bacteremia	-
ADL5859 30 mg	Phase 2	Acute Pain	-
MK-5684	Phase 2	Malignant Neoplasm	-
UFOX + Cetuximab	Phase 2	Previously Untreated Metastatic Colorectal Cancer	-
Ertugliflozin 1 mg	Phase 2	Diabetes Mellitus, Type 2	-
Ritonavir	Phase 2	HIV Infections	-
Coformulated favezelimab/pembrolizumab	Phase 2	Metastatic Urothelial Carcinoma	-
M5049 low dose	Phase 2	Systemic Lupus Erythematosus	-
Sofosbuvir	Phase 2	Hepatitis C	-
S-1	Phase 2	Gastric Cancer	-
Raludotatug Deruxtecan (R-DXd)	Phase 2	Gastrointestinal Cancer	-
MK-6213	Phase 2	Hypercholesterolemia	-
Tepotinib	Phase 2	Non-small Cell Lung Cancer	-
val-mCyd	Phase 2	Chronic Hepatitis C	-
MK-3795	Phase 2	VHL Gene Mutation	-
Efprezimod alfa	Phase 2	Graft Versus Host Disease	-
boceprevir (SCH 503034)	Phase 2	Chronic Hepatitis C	-
Favezelimab	Phase 2	Advanced Non-Small Cell Lung Cancer	-
tildrakizumab	Phase 2	Psoriasis	-
Letermovir oral granules	Phase 2	Cytomegalovirus (CMV) Infection	-
V114 Lot 1	Phase 2	Pneumococcal Infections	-
EBR/GZR FDC Tablet	Phase 2	HCV Infection	-
MK633	Phase 2	Chronic Obstructive Pulmonary Disease (COPD)	-
favezelimab/pembrolizumab	Phase 2	Hodgkin Lymphoma	-
MK0916	Phase 2	Diabetes Mellitus, Type 2	-
luspatercept	Phase 2	B-Thalassemia	-
Tulisokibart	Phase 2	Hidradenitis Suppurativa	-
Grazoprevir (GZR)	Phase 2	Hepatitis C Virus	-
MK0524A, niacin (+) laropiprant / Duration of Treatment: 17 Weeks	Phase 2	Flushing	-
Cabazitaxel	Phase 2	Prostatic Neoplasms, Castration-Resistant	-
adavosertib	Phase 2	Ovarian Cancer	-
L-dopa	Phase 2	Parkinson Disease	-
MK0364	Phase 2	Obesity	-
Donepezil	Phase 2	Alzheimer's Disease	-
Single low dose cyclophosphamide	Phase 2	Carcinoma, Non-Small-Cell Lung	-
MK0249	Phase 2	Attention-Deficit/Hyperactivity Disorder (ADHD)	-
ridaforolimus (MK8669)	Phase 2	Prostate Cancer	-
MK-8189	Phase 2	Schizophrenia, Acute Episode	-
I-DXd	Phase 2	Esophageal Squamous Cell Carcinoma	-
MK0683, vorinostat, Suberoylanilide Hydroxamic Acid (SAHA) / Duration of Treatment 6 Months	Phase 2	B-cell Lymphoma	-
Gefapixant 100 mg	Phase 2	Refractory Chronic Cough	-
MK-8435 (Org 25935) 4-8 mg	Phase 2	Schizophrenia	-
Recombinant human growth hormone (r-hGH)	Phase 2	Hypochondroplasia	-
Rolapitant Dose 1	Phase 2	Postoperative Nausea and Vomiting	-
ARQ 501 in combination with gemcitabine	Phase 2	Pancreatic Cancer	-
Vicriviroc 30 mg	Phase 2	HIV Infections	-
Stavudine	Phase 2	HIV Infections	-
MK-6096	Phase 2	Migraine	-
Pembrolizumab/vibostolimab coformulation	Phase 2	Bladder Cancer	-
valopicitabine	Phase 2	Chronic Hepatitis C	-
MK0677	Phase 2	Alzheimer's Disease	-
irinotecan hydrochloride	Phase 2	Metastatic Colorectal Cancer	-
MK0359	Phase 2	Pulmonary Disease, Chronic Obstructive	-
Boserolimab	Phase 2	Small Cell Lung Cancer	-
MK-0941	Phase 2	Type 2 Diabetes Mellitus	-
MK-1029 150 mg	Phase 2	Asthma	-
SCH 56592	Phase 2	Onychomycosis	-
2 NRTIs	Phase 2	Human Immunodeficiency Virus (HIV) Infection	-
PegIFN-2b	Phase 2	HIV Infections	-
Ramucirumab	Phase 2	Gastroesophageal Junction	-
Vaniprevir 600 mg b.i.d.	Phase 2	Hepatitis C, Chronic	-
MK0524	Phase 2	Seasonal Allergies	-
MK0991, caspofungin acetate/Duration of Treatment: variable	Phase 2	Candidiasis	-
PegIntron (peginterferon alfa-2b)	Phase 2	Hepatitis C, Chronic	-
Relebactam 250 mg	Phase 2	Intra-abdominal Infections	-
IDX719	Phase 2	Hepatitis C, Chronic	-
Atorvastatin/niacin extended-release	Phase 2	Carotid Atherosclerosis	-
medroxyprogesterone acetate tablets OR megestrol acetate	Phase 2	Endometrial Cancer	-
Rebif	Phase 2	Multiple Sclerosis	-
peginterferon alfa 2b	Phase 2	Hepatitis C, Chronic	-
TRUVADA®	Phase 2	HIV Infections	-
TR701 FA	Phase 2	Major Cutaneous Abscess	-
MK0524A, /Duration of Treatment : 8 Weeks	Phase 2	Flushing	-
Preladenant	Phase 2	Parkinson Disease	-
Antihistamine	Phase 2	Esophageal Squamous Cell Carcinoma	-
Recombinant human follicle stimulating hormone (r-hFSH)	Phase 2	Infertility	-
Lonafarnib	Phase 2	Breast Cancer	-
Ceftolozane/Tazobactam	Phase 2	Complicated Intra-Abdominal Infection	-
MK-0873	Phase 2	Rheumatoid Arthritis	-
Matuzumab	Phase 2	Esophageal Cancer	-
diquafosol tetrasodium (INS365) ophthalmic solution	Phase 2	Dry Eye Disease	-
MK2295	Phase 2	Pain, Postoperative	-
Oral testosterone undecanoate (Andriol)	Phase 2	Hypogonadism	-
V504	Phase 2	Cervical Cancer	-
Azithromycin ophthalmic solution, 1%	Phase 2	Blepharitis	-
Vorapaxar	Phase 2	Atherosclerosis	-
imipenem/cilastatin 500 mg	Phase 2	Urinary Tract Infections	-
Docetetaxel	Phase 2	Carcinoma, Non-Small-Cell Lung	-
ARQ 197 plus erlotinib	Phase 2	Metastatic Non-Small Cell Lung Cancer	-
Posaconazole IV 6 mg/kg	Phase 2	Invasive Fungal Infection	-
V114 Medium Dose	Phase 2	Pneumococcal Infections	-
Quavonlimab	Phase 2	Advanced Solid Tumors	-
V181 High-Potency Level	Phase 2	Dengue Disease	-
Biltricide (racemate praziquantel) oral tablets	Phase 2	Schistosomiasis	-
MK-1167	Phase 2	Alzheimer Disease	-
SCH 530348	Phase 2	Arterial Obstructive Diseases	-
Pertuzumab	Phase 2	Breast Neoplasms	-
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)	Phase 2	Infertility Implantation Failure	-
epinastine 0.1%	Phase 2	Allergic Rhinitis	-
Epinastine Nasal Spray	Phase 2	Seasonal Allergic Rhinitis	-
Clesrovimab	Phase 2	Respiratory Syncytial Viruses	-
Grazoprevir/Elbasvir FDC	Phase 2	Hepatitis C	-
Itraconazole	Phase 2	Chronic Hepatitis C	-
Doravirine, Tenofovir, Lamivudine - Blinded	Phase 2	HIV-1	-
V940	Phase 2	Squamous Non-small Cell Lung Cancer	-
MK-5442	Phase 2	Osteoporosis	-
R-DXD	Phase 2	Lung Neoplasm	-
Avelumab	Phase 2	Squamous Non-Small Cell Lung Cancer	-
MK-4830	Phase 2	Carcinoma, Non-Small-Cell Lung	-
Efinopegdutide	Phase 2	Metabolic Dysfunction-Associated Steatotic Liver Disease	-
Sacituzumab Tirumotecan (sac-TMT)	Phase 2	Gastroesophageal Junction	-
Pegylated Interferon (peg-IFN)	Phase 2	Hepatitis C	-
VigantOL oil plus interferon beta-1a (Rebif)	Phase 2	Relapsing-Remitting Multiple Sclerosis	-
zoster vaccine live (Oka/Merck)	Phase 2	Shingles	-
MK0429	Phase 2	Post-Menopausal Osteoporosis	-
Raludotatug Deruxtecan	Phase 2	Ovarian Cancer Recurrent	-
Dalantercept plus sorafenib	Phase 2	Advanced Adult Hepatocellular Carcinoma	-
Miransertib	Phase 2	PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)	-
Dacarbazine	Phase 2	Classical Hodgkin Lymphoma	-
Nelfinavir mesylate	Phase 2	HIV Infections	-
Coformulation favezelimab/pembrolizumab	Phase 2	Esophageal Squamous Cell Carcinoma (ESCC)	-
Risperidone	Phase 2	Schizophrenia	-
MK-0893	Phase 2	Diabetes Mellitus, Type 2	-
Islatravir	Phase 2	HIV-1 Infection	-
ibuprofen	Phase 2	Migraine	-
AR51 (12, 10)	Phase 2	Bacterial Infections; Virus Diseases	-
diphenhydramine	Phase 2	Carcinoma, Non-Small-Cell Lung	-
ZA	Phase 2	Breast Cancer	-
M5717 60 mg	Phase 2	Malaria Infection	-
L-756423	Phase 2	HIV Infections	-
Ruzasvir	Phase 2	Hepatitis C	-
Fosaprepitant	Phase 2	Chemotherapy-induced Nausea and Vomiting	-
timolol/dorzolamide combination	Phase 2	Glaucoma	-
MK8141	Phase 2	Hypertension	-
vinblastine	Phase 2	Hodgkin Lymphoma	-
Esmeron®	Phase 2	Neuromuscular Blockade	-
Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20	Phase 2	Papillomavirus Infections	-
Gefapixant 45 mg	Phase 2	Chronic Cough	-
Farnesyl Protein Transferase Inhibitor	Phase 2	Leukemia	-
Gefitinib	Phase 2	Non-small Cell Lung Carcinoma	-
Palbociclib	Phase 2	Renal Cell Carcinoma	-

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals

MRK News